FENFLURAMINE IN PRADER-WILLI SYNDROME: A DOUBLE BLIND, PLACEBO CONTROLLED TRIAL
Saved in:
SELIKOWITZ, M., ET AL., FENFLURAMINE IN PRADER-WILLI SYNDROME: A DOUBLE BLIND, PLACEBO CONTROLLED TRIAL. ARCHIVES OF DISEASE IN CHILDHOOD, Vol. 65, no. 1 (1990), p. 112-114.
Ref.
13911
Location:
SIIS R,186
Palabras clave:
Agresividad, Ceguera, Conducta, Enfermedades mentales, Fármacos, Obesidad, Peso, Síndrome de Prader-Willi, Tratamiento
Agresividad, Ceguera, Conducta, Enfermedades mentales, Fármacos, Obesidad, Peso, Síndrome de Prader-Willi, Tratamiento
Similar Items: FENFLURAMINE IN PRADER-WILLI SYNDROME: A DOUBLE BLIND, PLACEBO CONTROLLED TRIAL
- DIAGNOSIS IN PRADER-WILLI SYNDROME
- PRADER-WILLI SYNDROME: AN OVERVIEW
- PERCEPTIONS OF BODY IMAGE BY PERSONS WITH PRADER-WILLI SYNDROME AND THEIR PARENTS
- PRADER WILLI SYNDROME WITH HYPOTHYROIDISM
- NALTREXONE AND FLUOXETINE IN PRADER-WILLI SYNDROME
- Increasing physical activity in adult women with Prader–Willi syndrome: A transferability study